Position in MRK
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$43,843,900
-$1,217,906 QoQ
Shares Held
364,485
-14.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. MRK ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
|
50,366 | $17,721,277 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,843,900 | 364,485 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $45,061,806 | 428,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $45,691,492 | 544,400 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $44,456,256 | 561,600 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $50,418,192 | 561,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $57,370,116 | 576,700 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $62,151,388 | 547,300 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $38,043,740 | 307,300 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $31,206,175 | 236,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $18,631,518 | 170,900 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $7,710,955 | 74,900 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $10,004,313 | 86,700 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $16,320,226 | 153,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,890,940 | 125,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,891,156 | 161,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,252,741 | 167,300 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $14,117,088 | 184,200 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $9,418,794 | 125,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,189,181 | 105,300 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,623,007 | 137,800 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,791,455 | 119,700 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,112,513 | 97,800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,032,147 | 116,800 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,540,116 | 98,000 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||